Godrej Agrovet Q4 FY26 Results: FY26 Revenue Up 9%

Godrej Agrovet announced its Q4 FY26 financial results on April 30, 2026, through filings with the NSE and BSE. The Godrej Group agribusiness company operates across animal feeds, crop protection, dairy, poultry, and palm oil. The January to March 2026 quarter was marked by a year-on-year rise in revenue, even as the quarter saw a sequential decline from the preceding quarter. Alongside quarterly trends, the company also reported higher full-year revenue, profit after tax (PAT), and earnings per share (EPS) for FY26.

Key FY26 highlights reported by the company

For FY26, Godrej Agrovet reported revenue of ₹10,232.68 crore compared with ₹9,382.77 crore in FY25, a 9.06% year-on-year increase. PAT for FY26 came in at ₹445.18 crore versus ₹403.37 crore in FY25, up 10.36% year-on-year. EPS for FY26 was ₹24.58 compared with ₹22.35 in FY25, translating into 9.98% year-on-year growth. These full-year numbers indicate that profit growth slightly outpaced revenue growth on a year-on-year basis, as per the figures shared in the results context.

Q4 FY26 revenue: YoY growth, QoQ decline

In Q4 FY26, revenue was reported at ₹2,332.65 crore. This compared with ₹2,718.32 crore in Q3 FY26, implying a 14.21% quarter-on-quarter decrease. Against Q4 FY25 revenue of ₹2,133.64 crore, Q4 FY26 revenue was higher by 9.33% year-on-year. The sequential decline is important context because Q3 FY26 revenue had been described as a high point in recent quarters, while Q4 reverted to a lower level.

What the company said about segment drivers

In the Q4 FY26 context shared, the animal feed business was described as the largest segment and benefited from healthy demand from poultry, cattle, and aquaculture. The narrative also pointed to rising protein consumption in India as a structural driver for feed volumes. In crop protection, demand was described as mixed, with the rabi season and monsoon outlook shaping farmer purchasing decisions. The FY26 business summary described performance as steady across the diversified portfolio, with dairy operations improving and the palm oil business benefiting from higher crude palm oil prices.

Conference call schedule and participants

Godrej Agrovet scheduled its Q4 FY26 results conference call for May 4, 2026, at 3:00 PM IST. The participants listed for the call include Chairman Nadir Godrej, Chairman Designate Burjis Godrej, CEO and MD Sunil Kataria, CFO S. Varadaraj, and Executive Director and COO Arijit Mukherjee. For investors, this call is typically the forum to seek clarifications on quarterly movements, segment commentary, and any outlook items referenced by management.

How Q4 fits into the recent quarterly run-rate

The broader context provided alongside the results included Q3 FY26 consolidated revenue of ₹2,718 crore versus ₹2,450 crore in Q3 FY25, a year-on-year increase of 11.0%. Q3 FY26 EBITDA was reported at ₹260 crore versus ₹229 crore in Q3 FY25, with the EBITDA margin at 9.6% compared with 9.3%. Q3 FY26 PBT was reported at ₹169 crore versus ₹138 crore, while Q3 FY26 PAT was reported at ₹133 crore versus ₹99 crore. With Q4 revenue lower than Q3, readers should rely on the audited exchange filing for the full Q4 profitability and margin details beyond the revenue movement highlighted.

Historical profit and loss snapshot (FY21 to FY25)

A profit and loss table shared in the material provides a longer trendline up to Mar 2025. Net sales increased from ₹4,413.04 crore in Mar 2021 to ₹7,009.07 crore in Mar 2025, while total expenditure rose from ₹4,039.89 crore to ₹6,254.43 crore over the same period. Operating profit was ₹754.64 crore in Mar 2025 versus ₹575.44 crore in Mar 2024, based on the table. Other income and interest were also listed, indicating the presence of non-operating items and finance costs that can influence reported profitability.

Summary table: FY26 and recent quarterly revenue

Market impact: what the reported numbers signal

From the reported data points, FY26 shows a clear year-on-year rise in revenue, PAT, and EPS. The Q4 revenue pattern shows growth versus the year-ago quarter but a notable decline versus Q3 FY26. For market participants, this combination often prompts questions around seasonal demand, commodity-linked pricing, and segment mix changes across quarters. The company’s commentary highlighted demand in animal feeds and the role of crop season conditions in crop protection, which aligns with the observed quarter-to-quarter variability. Investors typically evaluate these trends alongside segment disclosures and audited statements in the NSE/BSE filings.

Analysis: why FY26 growth and Q4 sequencing matter

The FY26 performance indicates that Godrej Agrovet delivered profit growth slightly ahead of revenue growth, based on the reported YoY percentages. At the same time, the sequential revenue drop in Q4 underscores that quarter-to-quarter comparisons can vary meaningfully in agribusiness-linked portfolios. The qualitative references to monsoon outlook, rabi season demand, and crude palm oil prices show how external conditions can influence both volumes and realizations. With a conference call scheduled soon after results, investors will likely focus on management’s explanations for quarterly movement, segment-level performance, and the outlook framing for FY27.

Conclusion

Godrej Agrovet’s Q4 FY26 announcement, dated April 30, 2026, put out key FY26 headline numbers, including revenue of ₹10,232.68 crore, PAT of ₹445.18 crore, and EPS of ₹24.58. Q4 FY26 revenue rose 9.33% year-on-year to ₹2,332.65 crore, but fell 14.21% sequentially from Q3 FY26. The company’s Q4 commentary pointed to healthy demand in animal feeds and mixed conditions in crop protection. The next near-term milestone is the Q4 FY26 results conference call on May 4, 2026, where additional details are expected to be discussed.